Skip to main content
NewslettersWatchlist

Hologic Inc(HOLX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low76.50
Day High77.38
Open:76.76
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
BayStreet.ca
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases
PR Newswire
Jennifer Meade Named President at Aldevron
Barchart
Stocks Pressured by Corporate Earnings and Higher Bond Yields
Barchart
Most Stocks Under Pressure from Earnings and Higher Bond Yields
Barchart
Markets Today: Stocks Push Higher as Positive Q2 Bank Earnings Roll In
Newswire.ca
NATIONAL BANK OPEN PRESENTED BY ROGERS TO OFFER EQUAL PRIZE MONEY TO WOMEN AND MEN STARTING IN 2027
PR Newswire
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
PressReach
A New Groundbreaking Tool to Detect Colon Cancer Earlier
Business Wire
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
Business Wire
Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference
MarketBeat
Can Butterfly Network Spread its Wings in 2023?
Business Wire
Hologic Announces Financial Results for Second Quarter of Fiscal 2023
The Globe and Mail
13 U.S. health care stocks starting to shine again
Business Wire
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023
PR Newswire
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
BayStreet.ca
Breast Cancer Treatment Options Evolved Over the Last 12 Months, Bringing More Hope for 2023
Business Wire
Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference
Business Wire
Hologic “Making a World of Difference” Through Global Sustainability Impact
Business Wire
Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent
Business Wire
Hologic Announces Financial Results for First Quarter of Fiscal 2023
Business Wire
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023
Business Wire
Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference
TheNewswire.com
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Business Wire
Stacey D. Stewart Elected to Hologic Board of Directors
Business Wire
New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test for Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
Business Wire
Hologic Ranked #1 for Mammography System Performance and Customer Satisfaction for 10th Consecutive Year
Business Wire
Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
Business Wire
Hologic to Webcast Presentation at the 5th Annual Evercore ISI HealthCONx Conference
Business Wire
Hologic Announces Contract with BARDA to Support IVD Approval of COVID Assays
Barchart
Stocks Fade Ahead of Wednesday’s Expected 75 bp Fed Rate Hike
Barchart
Stocks Turn Lower as Strong U.S. Economic Data Fuels Hawkish Fed

Profile

Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.